Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis

By sjmartinez • October 4, 2022

Ferrada MA, Savic S, Cardona DO, Collins JC, Alessi H, Gutierrez-Rodrigues F, Kumar DBU, Wilson L, Goodspeed W, Topilow JS, Paik JJ, Poulter JA, Kermani TA, Koster MJ, Warrington KJ, Cargo C, Tattersall RS, Duncan CJA, Cantor A, Hoffmann P, Payne EM, Bonnekoh H, Krause K, Cowen EW, Calvo KR, Patel BA, Ombrello AK, Kastner DL, Young NS, Werner A, Grayson PC, Beck DB. Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis. Blood. 2022 Sep 29;140(13):1496-1506. doi: 10.1182/blood.2022016985. PMID: 35793467.

Tags: Rheumatology

Are we ready for home spirometry for systemic sclerosis-associated ILD?

Channick J, Volkmann ER. Are we ready for home spirometry for systemic sclerosis-associated ILD? Lancet Rheumatol. 2024 Nov 8:S2665-9913(24)00266-2. doi: 10.1016/S2665-9913(24)00266-2. Epub ahead of print.[...]

Influence of study characteristics on harm estimates from randomised controlled trials in patients with inflammatory arthritis receiving biological or synthetic antirheumatic drugs: a meta-epidemiological study

Berg JI, Nielsen SM, Malm E, Ioannidis JPA, Furst DE, Smolen JS, Taylor PC, Kristensen LE, Tarp S, Ellingsen T, Christensen R. Influence of study[...]

Understanding Late-Onset Interstitial Lung Disease in Systemic Sclerosis: Implications for Clinical Practice and Trial Design

Volkmann ER. Understanding Late-Onset Interstitial Lung Disease in Systemic Sclerosis: Implications for Clinical Practice and Trial Design. Arthritis Rheumatol. 2024 Nov 3. doi: 10.1002/art.43053. Epub[...]